Takeda Announces Positive Results from Two Pivotal Phase 3 Studies of Oveporexton (TAK-861) in Narcolepsy Type 1
-
14/05/2025, 09:03
-
ansa.it
0
Scopri altro
- 14/07/2025, 09:03
-
ansa.it
-
0
- 14/07/2025, 08:55
-
ansa.it
-
0
- 14/07/2025, 08:47
-
ansa.it
-
0
- 14/07/2025, 08:18
-
ansa.it
-
0
- 14/07/2025, 08:18
-
ansa.it
-
0
- 14/07/2025, 08:13
-
ansa.it
-
0
- 14/07/2025, 08:05
-
ansa.it
-
0
Nessun commento